Natus Medical Incorporated has announced the official launch of BrainWatch, the highly anticipated point-of-care EEG solution designed to bring the reliability and trust expected from the world’s largest neurodiagnostic company into critical-care environments.
The introduction of BrainWatch solves vital needs identified by customers desiring a point-of-care solution that would be easy to use and interface with NeuroWorks, the EEG platform trusted by more health systems and small hospitals worldwide.
Health Technology Insights: Pulnovo Gains EQT Investment After CE-MDR Approval
“In this day and age, brain-health professionals, including neurologists and EEG technicians, are in scarce supply,” said Natus CEO Chris Landon. “BrainWatch was designed to be both quickly and easily deployable in both the emergency room and the ICU, so more patients can be treated, including those in underserved communities.”
BrainWatch can be set up in less than five minutes, allowing quick intervention in acute care environments and streamlining treatment decisions with neurology support to improve patient care.
By leveraging the NeuroWorks platform, BrainWatch offers a familiar review experience with remote neurologist collaboration 24/7 from any web browser.
Health Technology Insights: SIME Diagnostics Unveils AI Lung Test Results in NICU
BrainWatch delivers the most complete ACNS-compliant rapid EEG solution for Critical Care, enabling full referential analysis. It also offers exclusive on-device software with integrated FDA-cleared Persyst algorithms for seizure detection and seizure burden, built on the industry-leading Persyst 15.
“We’ve found the EEG signal quality from the small, wearable, and wireless BrainWatch device to be impressive,” said Dr. Puneet Gupta, VP Health Innovation Strategy & Ventures at Neurology Consultants of Dallas. “BrainWatch also offers the ability to perform remontaging after the study, which can be useful in visualizing abnormalities, improving localization, and aiding in artifact identification.”
Health Technology Insights: Shift Bioscience Appoints Lord Prior and Sir Tony Kouzarides
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
